biomed

Savoirs

BRCA1 mutation analysis in breast and ovarian cancer families from Greece

Konstantopoulou I, Croupis C, Ladopoulou A, Pantazidis A, Lianidou E, Venetsanou K, Efstathiou E, Petersen M, Janinis J, Fountzilas G, Chiotellis E, Yannoukakos D

Savoirs

Breast cancer in young women: prevalence of LOH at p53, BRCA1 and BRCA2

Johnson Sm, Shaw Ja, Walker Ra, Walker

Savoirs

A novel BRCA2 gene mutation, 4081 insA, in a Finnish breast/ovarian cancer family associated with favourable clinical course

Hartikainen J, Kataja V, Mannermaa, Mannermaa A

Savoirs

Denaturing high-performance liquid chromatography (DHPLC) as a fast tool to screen a control population for the occurrence of unclassified variants (UV) in the BRCA1 gene

Arnold N, Peper H, Bandick K, Jonat W, Kiechle, Kiechle M, Grosse

Savoirs

Relation of gene expression-based tumor subclasses to clinical phenotypes

Sørlie T, Perou Cm, Lønning Pe, Brown Po, Botstein D, Børresen-Dale, Børresen-Dale A-L

Savoirs

Transcript profiles and genotyping of cancer tissue

Malmqvist C, Sievertzon M, Gustafsson A, Holmberg A, Larsson M, Alderborn A, Uhlén M, Lundeberg, Lundeberg J

Savoirs

Comparative genomic hybridisation analysis of myoepithelial carcinoma of the breast

Jones C, Foschini Mp, Chaggar R, Lu Y-J, Wells D, Shipley Jm, Eusebi V, Lakhani, Lakhani Sr

Savoirs

Hypervariable area in the 5' flanking region of GSTP1, previously reported as a minisatellite repeat

Nedelcheva, Kristensen T, Børresen-Dale, Børresen-Dale A-L

Savoirs

Screening for BRCA1 gene mutations by capillary electrophoretic REF-SSCP

Kringen P, Eiken Hg, Pedersen Jc, Egedal S, Berg K, Tveit Km, Andersen Ti, Andersen

Savoirs

Exact quantification of gene amplification in archival tissue sections by laser-assisted microdissection and real-time PCR

Lehmann U, Glöckner S, Kleeberger W, Kreipe, Kreipe H, Von

Savoirs

REAL Real-Time!

Boeckman F, Tan L, Hamby, Hamby K

Savoirs

Promising method for DNA extraction from paraffin embedded archive material

Bregård A, Vu P, Geitvik G, Børresen-Dale, Børresen-Dale A-L

Savoirs

Cytokeratin and mammaglobin as tumor markers in patients with high risk breast cancer

Ferrucci Pf, Rabascio C, Corsini C, Tealdo F, Paolucci M, Bertolini F, El, Martinelli, Martinelli G

Savoirs

Does a polymorphism in the CYP17 gene predict mammographic density?

Ursin G, Ingles Sa, Coetzee Ga, Bernstein L, Pike Mc, Buley, Buley A, Spencer

Savoirs

AKT-1 and BCL-2 co-expression in breast cancer patients correlates with better survival

Pérez-Tenorio G, Stål, Stal O

Savoirs

Angiogenesis in breast cancer: establishing a link between angiogenesis and hormone regulation

Soares R, Costa C, Gärtner F, Schmitt F, Schmitt

Savoirs

Setting up an efficient and reliable screening method for novel c-Jun N-terminal kinase substrates

Kallunki T, Holmberg C, Lerdrup-Hansen M, Herdegen T, Aronheim A, Jäättelä, Jäättelä M

Savoirs

Negative regulation of p53 expression is an essential, rate-limiting function of Jun in the control of cell cycle progression

Schreiber M, Piu F, Kolbus A, Szabowski A, Möhle-Steinlein U, Tian J, Karin M, Angel P, Wagner Ef, Wagner

Savoirs

P16INK4A as a predictive factor in patients with locally advanced breast cancer treated with neoadjuvant doxorubicin monotherapy

Geisler S, Smith-Sørensen B, Betticher D, Bukholm Ik, Akslen La, Kappeler A, Gugger M, Lønning Pe, Børresen-Dale, Børresen-Dale A-L

Savoirs

A detailed physical map of a region within human chromosome 16q22.1

Frengen E, Rocca-Serra P, Shaposhnikov S, Taine L, Thorsen J, Bépoldin C, Longy M, Prydz H, Dorion-Bonnet, Dorion-Bonnet F

Savoirs

Analysis of Fhit expression in stages of breast cancer progression

Campiglio M, Somenzi G, Aiello P, Wärnberg F, Holmberg L, Croce Cm, Menard S, Menard

Savoirs

Embryonic lethality in the Brca1-1700T mouse model suggests inhibition of p53-dependent pathways

Hohenstein P, Kielman M, Breukel C, Krimpenfort P, Berns A, Bennett M, Wiseman R, Cornelisse C, Devilee P, Fodde R, Van

Savoirs

Screening breast cancer patients for Norwegian ATM mutations

Laake K, Vu P, Andersen Ti, Erikstein B, Kåresen R, Lønning Pe, Skovlund E, Børresen-Dale, Børresen-Dale A-L

Savoirs

The GSTT1 genotype is associated with p53 mutation status of breast cancer tumours

Gudmundsdóttir K, Tryggvadóttir L, Eyfjörd, Eyfjörd Je

Savoirs

BRCA2 interacting proteins

Vidarsson H, Mikaelsdottir E, Eyfjörd Je, Ögmundsdóttir H, Rafnar T, Valgeirsdóttir, Valgeirsdóttir S

Savoirs

Role of the breast cancer susceptibility gene BRCA1 in radio-resistance

Sylvain V, Bignon, Bignon Y-J

Savoirs

HER-2 activation and TP53 inactivation as predictors of survival in breast cancer

Andersen Ti, Skovlund E, Bukholm Ik, Jacobsen U, Kåresen R, Erikstein B, Nesland J, Børresen-Dale, Børresen-Dale A-L

Savoirs

Factors modulating integrin Beta I expression on the breast cancer cell lines MCF-7 and MDA-MB-231

Pogson Cj, Chan Cmw, Martin L-A, Gui Gph, Dowsett, Dowsett M

Savoirs

Activation of the Her2/neu receptor leads to antiestrogen resistance, but acquired resistance is not caused by altered ErbB expression and activation

Larsen Ss, Lykkesfeldt, Lykkesfeldt Ae

Savoirs

IGFBP-7 expression in human breast cancer and association with proliferation and cell cycle aberrations

Östlund H, Burger A, Seth A, Landberg, Landberg G